Daniel Woolson - 06 Mar 2023 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Reporting relationship: VP, GM-Infusion Capital
Issuer ticker: ICUI
Reported as of: 06 Mar 2023
Net transaction value: -$307,956
SEC form: 4
Accepted by SEC: 08 Mar 2023, 16:09:27 UTC
Prior SEC filing: 02 Feb 2023
Next SEC filing: 01 Dec 2023
Source filing: View source filing
Reporting owner signature: By: Paula Darbyshire, Attorney-in-fact For: Daniel Woolson

Key filing fact

Daniel Woolson filed Form 4 for ICU MEDICAL INC/DE (ICUI) on 08 Mar 2023.

Key facts

This page summarizes Daniel Woolson's Form 4 filing for ICU MEDICAL INC/DE (ICUI).
9 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 08 Mar 2023, 16:09.

Change

Previous filing in this sequence was filed on 02 Feb 2023.
Current net transaction value: -$307,956.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ICUI transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +1,417
Change %: +15%
Price: $0.000000
Shares after: 10,569
Date: 06 Mar 2023
Ownership: Direct

ICUI transaction

Common Stock

Tax liability

Transaction value: $100,942
Shares: -626
Change %: -5.9%
Price: $161.25
Shares after: 9,943
Date: 06 Mar 2023
Ownership: Direct

ICUI transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +965
Change %: +9.7%
Price: $0.000000
Shares after: 10,908
Date: 07 Mar 2023
Ownership: Direct

ICUI transaction

Common Stock

Tax liability

Transaction value: $67,397
Shares: -428
Change %: -3.9%
Price: $157.47
Shares after: 10,480
Date: 07 Mar 2023
Ownership: Direct

ICUI transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +2,020
Change %: +19%
Price: $0.000000
Shares after: 12,500
Date: 08 Mar 2023
Ownership: Direct

ICUI transaction

Common Stock

Tax liability

Transaction value: $139,616
Shares: -894
Change %: -7.2%
Price: $156.17
Shares after: 11,606
Date: 08 Mar 2023
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ICUI transaction Derivative

Common Stock

Options Exercise

Transaction value: $0
Shares: -965
Change %: -33%
Price: $0.000000
Shares after: 1,932
Date: 07 Mar 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 965
Exercise price: $0.000000
Footnotes: F1, F2, F3, F4

ICUI transaction Derivative

Performance Shares

Options Exercise

Transaction value: $0
Shares: -2,020
Change %: -50%
Price: $0.000000
Shares after: 2,020
Date: 08 Mar 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,020
Exercise price: $0.000000
Footnotes: F5, F6

ICUI transaction Derivative

Performance Shares

Options Exercise

Transaction value: $0
Shares: -1,417
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 06 Mar 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,417
Exercise price
Footnotes: F5, F7, F8

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

These securities are Restricted Stock Units.

Footnote F2

There is neither a purchase price nor an exercise price for the Restricted Stock Units.

Footnote F3

One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

Footnote F4

These are restricted stock units that fully vest 3 years from the grant date.

Footnote F5

These Securities are Performance-based Restricted Stock Units (PRSU).

Footnote F6

These PRSUs were granted on March 8, 2021. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 8 of the first, second, and third year following the year of grant.

Footnote F7

There is neither a purchase price nor an exercise price for the PRSUs.

Footnote F8

These PRSUs were granted on March 6, 2020. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 6 of the first, second, and third year following the year of grant.